Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-11 to 2024-01-12
Current total value of award: $4195.02
Description: 4563308797!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML